The antibodies recognizing clinical breast cancer cell marker proteins ER, PR, and HER-2 do not recognize CCT marker proteins in these breast cancer samples (n = 213 patients, SI Appendix, Fig. S4A). This evidence concerns the gene FLVCR2 and breast cancer.